首頁 > 市場調查報告書 > 消費品

健康美容口腔衛生

市場調查報告書

商品編碼

2044326

微生物組驅動的口腔護理市場預測至2034年：按產品類型、微生物菌株類型、配方技術、應用、分銷管道、最終用戶和地區分類的全球分析

Microbiome-Based Oral Care Market Forecasts to 2034 - Global Analysis By Product Type, Microbial Strain Type, Formulation Technology, Application, Distribution Channel, End User and By Geography

出版日期: 2026年05月11日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，預計到 2026 年，全球基於微生物組的口腔護理市場將達到 14 億美元，並在預測期內以 15.0% 的複合年成長率成長，到 2034 年達到 43 億美元。

以微生物組為基礎的口腔護理是指旨在維持、恢復和最佳化口腔內天然存在的微生物生態系統的牙科和口腔衛生產品，而非像傳統抗菌口腔護理產品那樣不加選擇地清除口腔中的細菌。這些產品含有經臨床鑑定的益生菌菌株，例如唾液鏈球菌K12和M18、羅伊氏乳桿菌和鼠李糖乳桿菌，這些菌株經過篩選，具有特定的口腔健康益處，例如競爭性地消除病原體、減少揮發性硫化物、改善牙齦炎和抑制致齲菌。產品形式包括益生菌牙膏、含有植物來源抗菌成分的益生菌漱口水（可替代酒精配方）、益生菌片劑和口香糖、益生菌噴霧劑以及針對特定用途的訂製牙粉混合物。

消費者對口腔健康與整體健康之間連結的認知

隨著臨床醫生和消費者對口腔微生物群與全身健康之間關聯的認知不斷提高——口腔菌群異常與心血管疾病、糖尿病併發症、呼吸道感染疾病、妊娠併發症和阿茲海默症疾病風險增加有關——口腔微生物群健康正從單純的口腔衛生問題演變為整體健康管理中的重中之重。牙周病專家和牙科保健員進行的口腔微生物群科學教育工作，正為那些能夠保護口腔微生物群免受傳統抗菌牙膏和含酒精漱口水破壞的口腔清潔用品贏得專業人士的支持。隨著消費者擴大將口腔益生菌產品作為全身健康策略的一部分進行投資，這一品類正不斷拓展，不再局限於口腔保健補充劑這一小眾領域。

消費者對傳統口腔護理的行為慣性

消費者根深蒂固的習慣和對傳統牙膏漱口水配方的品牌忠誠度，從童年時期養成，並持續數十年購買，這構成了微生物組口腔清潔用品產品推廣的一大障礙，因為這些產品挑戰了消費者對基本衛生習慣的認知。強效抗菌口腔清潔用品零售貨架上，微生物組口腔護理產品的陳列挑戰也進一步限制了其發現。

制定兒童口腔微生物組健康計劃

針對兒童早期口腔微生物群建立的關鍵發展階段（口腔菌群組成在此階段建立並產生長期健康影響），針對此階段的干涉措施，為微生物群口腔清潔用品提供了重要的臨床應用機會。兒童牙醫建議對易患齲齒的兒童進行口腔益生菌治療，使用添加益生菌的兒童牙膏幫助兒童養成支持微生物群的早期口腔衛生習慣，以及為孕婦提供旨在促進有益的垂直口腔微生物群傳遞的口腔益生菌補充劑，這些都為市場定位提供了臨床支持，並有望建立起覆蓋從嬰兒期到成年期全家適用的各類產品。

臨床證據標準及牙科專業人員的懷疑態度

牙科專業人士對口腔益生菌產品臨床證據基礎的質疑，阻礙了在醫療保健相關專業管道中製定推薦意見，而這對於高階口腔清潔用品品牌的信譽至關重要。多個市場的牙科協會已發布謹慎的口腔益生菌指南，直至獲得大規模的隨機對照試驗證據，這在專業界造成了不確定性，並限制了牙科診所推薦方案的製定。針對不同口腔微生物組環境設計標準化的口腔益生菌產品臨床試驗的複雜性，給證據生成帶來了挑戰，並延長了概念驗證研究的臨床檢驗週期，從而影響了產品分類的建立。

新型冠狀病毒（COVID-19）的影響：

疫情期間，由於醫療服務受限，人們對牙科護理的焦慮情緒加劇，加深了對口腔和呼吸系統健康以及新冠病毒感染風險之間聯繫的認知，從而提高了人們對口腔衛生的關注。同時，人們對免疫力的重視也激發了消費者對口腔益生菌產品的興趣，這類產品透過最佳化口腔微生物群來增強全身免疫力。即使在疫情結束後，人們對口腔健康與全身健康之間聯繫的持續關注，以及對微生物群健康的持續興趣，仍然保持著消費者對基於微生物群的口腔護理產品的高度接受度。

在預測期內，益生菌片細分市場預計將佔據最大的市場佔有率。

預計益生菌片劑將在預測期內佔據最大的市場佔有率。這是因為緩釋錠劑和片劑能夠確保益生菌以更高的存活率和更長的口腔接觸時間發揮作用，而漱口水和漱喉劑等產品則會限制活性益生菌的定植時間。專為刷牙後使用而設計的口腔益生菌片劑和錠劑，能夠促進口腔內有益菌的定植，從而有效改善現有口腔衛生習慣，因此受到注重口腔衛生的消費者的青睞。

在預測期內，乳酸菌菌株細分市場預計將呈現最高的複合年成長率。

在預測期內，乳酸菌菌株細分市場預計將呈現最高的成長率。這主要得益於口腔益生菌微生物組領域內最龐大的臨床證據基礎，這些證據支持特定乳酸菌菌株在預防齲齒、改善牙齦炎和維護牙周組織健康方面的功效。菌株特異性臨床試驗數據，例如羅伊氏乳桿菌和鼠李糖乳桿菌，能夠精準定位健康功效聲明，並吸引尋求循證益生菌差異化的口腔護理品牌進行產品開發投資。此外，牙科專業人士對特定乳酸桿菌菌株益處的認知不斷提高，也推動了專家推薦管道的發展。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其龐大的口腔護理消費市場、消費者對微生物組健康的高度關注以及功能性口腔健康產品先進的零售基礎設施。美國在市場中處於領先地位，這得益於牙科專業管道對循證口腔益生菌產品的大量投資，以及消費者透過專業醫療保健零售網路對天然口腔護理產品的日益成長的接受度。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。這主要歸因於中國、印度、日本和東南亞地區口腔疾病的高發生率，為臨床口腔微生物組干預創造了巨大的市場潛力；此外，消費者對天然和功能性口腔清潔用品的接受度也在迅速提高。日本先進的機能性食品和保健品文化推動了消費者對口腔益生菌產品的早期接受，從而影響該地區市場的成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域細分
- 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第12章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第13章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第14章：公司簡介

Colgate-Palmolive Company
Procter & Gamble Co.
GlaxoSmithKline plc
Johnson & Johnson
Unilever PLC
Haleon plc
Sunstar Group
Church & Dwight Co., Inc.
Lion Corporation
Dentsply Sirona Inc.
3M Company
Kenvue Inc.
Oral-B（P&G）
Hyperbiotics
BioGaia AB
NatureWise
Garden of Life

簡介目錄圖表

Product Code: SMRC36115

According to Stratistics MRC, the Global Microbiome-Based Oral Care Market is accounted for $1.4 billion in 2026 and is expected to reach $4.3 billion by 2034 growing at a CAGR of 15.0% during the forecast period. Microbiome-based oral care refers to dental and oral hygiene products formulated to preserve, restore, and optimize the oral cavity's resident microbial ecosystem rather than indiscriminately eliminating all oral bacteria as conventional antimicrobial oral care products do. These products incorporate clinically characterized probiotic strains including Streptococcus salivarius K12 and M18, Lactobacillus reuteri, and Lactobacillus rhamnosus selected for specific oral health benefits including pathogenic bacteria competitive exclusion, volatile sulfur compound reduction, gingivitis resolution, and caries pathogen suppression. Formats include probiotic-enriched toothpastes, biome-friendly mouthwashes using botanical antimicrobials over alcohol-based formulations, oral probiotic lozenges and chewing gums, probiotic spray applications, and targeted dental powder blends.

Market Dynamics:

Driver:

Oral-systemic health connection consumer awareness

Growing clinical and consumer awareness of the oral microbiome's systemic health connections linking dysbiotic oral flora to cardiovascular disease, diabetes complications, respiratory infections, pregnancy complications, and Alzheimer's disease risk is elevating oral microbiome health from cosmetic hygiene concern to systemic health management priority. Periodontist and dental hygienist communication of oral microbiome science is creating professional endorsement for microbiome-preserving oral care products that conventional antimicrobial toothpastes and alcohol mouthwashes disrupt. Consumer investment in oral probiotic products as part of integrated systemic health management strategies is driving category expansion beyond niche dental health supplement positioning.

Restraint:

Consumer behavioral inertia toward conventional oral care

Deep-rooted consumer behavioral habits and brand loyalty to established conventional toothpaste and mouthwash formulations developed through childhood and maintained across decades of consistent purchasing create substantial adoption barriers for microbiome-based oral care alternatives requiring consumers to revise fundamental hygiene routine assumptions. The perceived superior clean sensation and breath freshening of strong antimicrobial oral care products compared to gentler microbiome-friendly alternatives creates sensory expectation gaps that challenge trial conversion. Retail shelf placement challenges in oral care aisles dominated by major conventional brand share further limit microbiome oral care product discoverability.

Opportunity:

Pediatric oral microbiome health program development

Early childhood oral microbiome colonization programs targeting the critical developmental window when oral flora composition is established with lasting health consequences represent a high-impact clinical opportunity for microbiome oral care products. Pediatric dentist recommendation of oral probiotic protocols for cavity-prone children, probiotic-enriched children's toothpastes for microbiome-supportive early oral hygiene establishment, and maternal oral probiotic supplementation during pregnancy for beneficial vertical oral microbiome transmission are clinically grounded positioning opportunities that create family-penetrating category adoption from early childhood through adulthood.

Threat:

Clinical evidence standards and dental professional skepticism

Dental professional community skepticism regarding the clinical evidence base for oral probiotic products creates recommendation adoption barriers in the healthcare-adjacent professional channel that is critical for premium microbiome oral care brand credibility. Dental associations in multiple markets have issued cautious guidance on oral probiotics pending larger randomized controlled trial evidence packages, creating professional community ambivalence that limits dental office recommendation program development. The complexity of designing standardized clinical trials for oral probiotic products in diverse oral microbiome environments creates evidence generation challenges that extend clinical validation timelines for category-establishing proof-of-concept studies.

Covid-19 Impact:

The pandemic elevated oral health awareness through both increased dental anxiety from service access limitations and growing understanding of oral-respiratory health connections relevant to COVID-19 transmission risk. Heightened immunity consciousness created consumer interest in oral probiotic products positioned for systemic immune support through oral microbiome optimization. Post-pandemic, sustained awareness of oral-systemic health connections and interest in microbiome wellness maintains elevated consumer receptivity to microbiome-based oral care product adoption.

The probiotic tablets segment is expected to be the largest during the forecast period

The probiotic tablets segment is expected to account for the largest market share during the forecast period, due to the high probiotic viability delivery and extended oral cavity contact time that slow-dissolving lozenge and tablet formats achieve compared to rinse-off toothpaste and mouthwash applications that limit viable probiotic residence time. Oral probiotic tablets and lozenges formulated for post-brushing use establish beneficial bacterial colonization in the oral cavity following conventional cleaning, creating a complementary two-step oral care protocol that premium oral health consumers adopt as a functional upgrade to existing hygiene routines.

The lactobacillus strains segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the lactobacillus strains segment is predicted to witness the highest growth rate, driven by the largest clinical evidence base among oral probiotic microorganism categories supporting specific Lactobacillus strains for documented caries prevention, gingivitis resolution, and periodontal health maintenance. Lactobacillus reuteri and Lactobacillus rhamnosus strain-specific clinical trial data enabling precise health claim positioning is attracting formulation investment from oral care brands seeking science-substantiated probiotic differentiation, and growing dental professional awareness of specific Lactobacillus strain benefits is creating professional recommendation channel development.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the largest oral care consumer market, high consumer awareness of microbiome health, and advanced functional oral health product retail infrastructure. The United States leads with significant professional dental channel investment in evidence-based oral probiotic products and growing consumer natural oral care product adoption through specialty health retail networks.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to high oral disease prevalence creating large addressable clinical oral microbiome intervention markets in China, India, Japan, and Southeast Asia combined with rapidly growing consumer natural and functional oral care product adoption. Japan's advanced functional food and supplement culture is driving early oral probiotic product consumer adoption that is influencing regional market development.

Key players in the market

Some of the key players in Microbiome-Based Oral Care Market include Colgate-Palmolive Company, Procter & Gamble Co., GlaxoSmithKline plc, Johnson & Johnson, Unilever PLC, Haleon plc, Sunstar Group, Church & Dwight Co., Inc., Lion Corporation, Dentsply Sirona Inc., 3M Company, Kenvue Inc., Oral-B (P&G), Hyperbiotics, BioGaia AB, NatureWise, and Garden of Life.

Key Developments:

In March 2026, BioGaia AB launched a clinical-grade oral probiotic lozenge with Ligilactobacillus reuteri DSM 17938 demonstrating validated gingivitis reduction and pathogenic oral bacteria competitive exclusion in randomized controlled trials.

In March 2026, Haleon plc introduced a microbiome-friendly mouthwash formulation using botanical antimicrobials that selectively reduce pathogenic oral flora while preserving beneficial commensal bacteria versus conventional alcohol-based formulas.

In February 2026, Colgate-Palmolive Company released a probiotic-enriched toothpaste range incorporating heat-stable Lactobacillus strains validated for cariogenic bacteria suppression and oral microbiome diversity maintenance in clinical consumer studies.

Product Types Covered:

Toothpaste
Mouthwash
Oral Sprays
Chewing Gums
Probiotic Tablets
Dental Powders

Microbial Strain Types Covered:

Lactobacillus Strains
Bifidobacterium Strains
Streptococcus Salivarius
Multi-Strain Formulations

Formulation Technologies Covered:

Encapsulated Probiotics
Time-Release Formulations
Liquid Suspensions
Freeze-Dried Formulations

Applications Covered:

Caries Prevention
Gum Health
Breath Freshening
Whitening Support
Oral Microbiome Balance

Distribution Channels Covered:

Pharmacies
Online Retail
Supermarkets
Dental Clinics

End Users Covered:

Adults
Children
Dental Professionals
Hospitals & Clinics

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Microbiome-Based Oral Care Market, By Product Type

5.1 Toothpaste
5.2 Mouthwash
5.3 Oral Sprays
5.4 Chewing Gums
5.5 Probiotic Tablets
5.6 Dental Powders

6 Global Microbiome-Based Oral Care Market, By Microbial Strain Type

6.1 Lactobacillus Strains
6.2 Bifidobacterium Strains
6.3 Streptococcus Salivarius
6.4 Multi-Strain Formulations

7 Global Microbiome-Based Oral Care Market, By Formulation Technology

7.1 Encapsulated Probiotics
7.2 Time-Release Formulations
7.3 Liquid Suspensions
7.4 Freeze-Dried Formulations

8 Global Microbiome-Based Oral Care Market, By Application

8.1 Caries Prevention
8.2 Gum Health
8.3 Breath Freshening
8.4 Whitening Support
8.5 Oral Microbiome Balance

9 Global Microbiome-Based Oral Care Market, By Distribution Channel

9.1 Pharmacies
9.2 Online Retail
9.3 Supermarkets
9.4 Dental Clinics

10 Global Microbiome-Based Oral Care Market, By End User

10.1 Adults
10.2 Children
10.3 Dental Professionals
10.4 Hospitals & Clinics

11 Global Microbiome-Based Oral Care Market, By Geography

11.1 North America
- 11.1.1 United States
- 11.1.2 Canada
- 11.1.3 Mexico
11.2 Europe
- 11.2.1 United Kingdom
- 11.2.2 Germany
- 11.2.3 France
- 11.2.4 Italy
- 11.2.5 Spain
- 11.2.6 Netherlands
- 11.2.7 Belgium
- 11.2.8 Sweden
- 11.2.9 Switzerland
- 11.2.10 Poland
- 11.2.11 Rest of Europe
11.3 Asia Pacific
- 11.3.1 China
- 11.3.2 Japan
- 11.3.3 India
- 11.3.4 South Korea
- 11.3.5 Australia
- 11.3.6 Indonesia
- 11.3.7 Thailand
- 11.3.8 Malaysia
- 11.3.9 Singapore
- 11.3.10 Vietnam
- 11.3.11 Rest of Asia Pacific
11.4 South America
- 11.4.1 Brazil
- 11.4.2 Argentina
- 11.4.3 Colombia
- 11.4.4 Chile
- 11.4.5 Peru
- 11.4.6 Rest of South America
11.5 Rest of the World (RoW)
- 11.5.1 Middle East
  - 11.5.1.1 Saudi Arabia
  - 11.5.1.2 United Arab Emirates
  - 11.5.1.3 Qatar
  - 11.5.1.4 Israel
  - 11.5.1.5 Rest of Middle East
- 11.5.2 Africa
  - 11.5.2.1 South Africa
  - 11.5.2.2 Egypt
  - 11.5.2.3 Morocco
  - 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

12.1 Industry Value Network and Supply Chain Assessment
12.2 White-Space and Opportunity Mapping
12.3 Product Evolution and Market Life Cycle Analysis
12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

13.1 Mergers and Acquisitions
13.2 Partnerships, Alliances, and Joint Ventures
13.3 New Product Launches and Certifications
13.4 Capacity Expansion and Investments
13.5 Other Strategic Initiatives

14 Company Profiles

14.1 Colgate-Palmolive Company
14.2 Procter & Gamble Co.
14.3 GlaxoSmithKline plc
14.4 Johnson & Johnson
14.5 Unilever PLC
14.6 Haleon plc
14.7 Sunstar Group
14.8 Church & Dwight Co., Inc.
14.9 Lion Corporation
14.10 Dentsply Sirona Inc.
14.11 3M Company
14.12 Kenvue Inc.
14.13 Oral-B (P&G)
14.14 Hyperbiotics
14.15 BioGaia AB
14.16 NatureWise
14.17 Garden of Life

簡介目錄圖表

List of Tables

Table 1 Global Microbiome-Based Oral Care Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Microbiome-Based Oral Care Market Outlook, By Product Type (2023-2034) ($MN)
Table 3 Global Microbiome-Based Oral Care Market Outlook, By Toothpaste (2023-2034) ($MN)
Table 4 Global Microbiome-Based Oral Care Market Outlook, By Mouthwash (2023-2034) ($MN)
Table 5 Global Microbiome-Based Oral Care Market Outlook, By Oral Sprays (2023-2034) ($MN)
Table 6 Global Microbiome-Based Oral Care Market Outlook, By Chewing Gums (2023-2034) ($MN)
Table 7 Global Microbiome-Based Oral Care Market Outlook, By Probiotic Tablets (2023-2034) ($MN)
Table 8 Global Microbiome-Based Oral Care Market Outlook, By Dental Powders (2023-2034) ($MN)
Table 9 Global Microbiome-Based Oral Care Market Outlook, By Microbial Strain Type (2023-2034) ($MN)
Table 10 Global Microbiome-Based Oral Care Market Outlook, By Lactobacillus Strains (2023-2034) ($MN)
Table 11 Global Microbiome-Based Oral Care Market Outlook, By Bifidobacterium Strains (2023-2034) ($MN)
Table 12 Global Microbiome-Based Oral Care Market Outlook, By Streptococcus Salivarius (2023-2034) ($MN)
Table 13 Global Microbiome-Based Oral Care Market Outlook, By Multi-Strain Formulations (2023-2034) ($MN)
Table 14 Global Microbiome-Based Oral Care Market Outlook, By Formulation Technology (2023-2034) ($MN)
Table 15 Global Microbiome-Based Oral Care Market Outlook, By Encapsulated Probiotics (2023-2034) ($MN)
Table 16 Global Microbiome-Based Oral Care Market Outlook, By Time-Release Formulations (2023-2034) ($MN)
Table 17 Global Microbiome-Based Oral Care Market Outlook, By Liquid Suspensions (2023-2034) ($MN)
Table 18 Global Microbiome-Based Oral Care Market Outlook, By Freeze-Dried Formulations (2023-2034) ($MN)
Table 19 Global Microbiome-Based Oral Care Market Outlook, By Application (2023-2034) ($MN)
Table 20 Global Microbiome-Based Oral Care Market Outlook, By Caries Prevention (2023-2034) ($MN)
Table 21 Global Microbiome-Based Oral Care Market Outlook, By Gum Health (2023-2034) ($MN)
Table 22 Global Microbiome-Based Oral Care Market Outlook, By Breath Freshening (2023-2034) ($MN)
Table 23 Global Microbiome-Based Oral Care Market Outlook, By Whitening Support (2023-2034) ($MN)
Table 24 Global Microbiome-Based Oral Care Market Outlook, By Oral Microbiome Balance (2023-2034) ($MN)
Table 25 Global Microbiome-Based Oral Care Market Outlook, By Distribution Channel (2023-2034) ($MN)
Table 26 Global Microbiome-Based Oral Care Market Outlook, By Pharmacies (2023-2034) ($MN)
Table 27 Global Microbiome-Based Oral Care Market Outlook, By Online Retail (2023-2034) ($MN)
Table 28 Global Microbiome-Based Oral Care Market Outlook, By Supermarkets (2023-2034) ($MN)
Table 29 Global Microbiome-Based Oral Care Market Outlook, By Dental Clinics (2023-2034) ($MN)
Table 30 Global Microbiome-Based Oral Care Market Outlook, By End User (2023-2034) ($MN)
Table 31 Global Microbiome-Based Oral Care Market Outlook, By Adults (2023-2034) ($MN)
Table 32 Global Microbiome-Based Oral Care Market Outlook, By Children (2023-2034) ($MN)
Table 33 Global Microbiome-Based Oral Care Market Outlook, By Dental Professionals (2023-2034) ($MN)
Table 34 Global Microbiome-Based Oral Care Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)